Navigation LinksBiology NewsHealth NewsBiology TechnologyMedicine Technology


We're sorry, that page (http://www.bio-medicine.org/biology-technology-1/spinesmith-partners-and-genosteo-announce-collaborative-product-development-agreement-14733-1/;msg90356) was not found.

Search biology technology 1 spinesmith partners and genosteo announce collaborative product development agreement 14733 1 ;msg90356 at Google

Search biology technology 1 spinesmith partners and genosteo announce collaborative product development agreement 14733 1 ;msg90356 at Yahoo

Search biology technology 1 spinesmith partners and genosteo announce collaborative product development agreement 14733 1 ;msg90356 at Msn

Google
 
(Date:11/25/2009)...NA, Calif.Scientists at the California Institute o...a primitive emotion-like behavior in the fruit fly...hich may be relevant to the relationship between t... hyperactivity disorder (ADHD), are described in t... Drosophila brain contains only about 20,000 neu...
(Date:11/25/2009)...tember 11, firefighters, police officers and ambul...he World Trade Center complex. They battled to sav... for survivors, tackled fires and evacuated as man...an estimated 17,000 people. And making their jobs ...: frightened workers and their relatives jammed mo...
(Date:11/25/2009)...he course of a lifetime, the heart pumps some 250 ...rder to do this, the muscle fibers of the heart ha...ded by Dr. Wolfgang Rottbauer, vice chair of the D... Hospital (Chairman: Prof. Dr. H. A. Katus), has d...ability of the smallest muscular unit, the sarcome...
Breaking Biology News(10 mins):Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 2Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 3Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 4Magic box for mission impossible 2Magic box for mission impossible 3New genetic cause of cardiac failure discovered 2Wolters Kluwer Health Appoints Anne Woods to Chief Nursing Officer 3B Strengthens Its Commitment to the Nursing Market 60802 1Wolters Kluwer Health Appoints Anne Woods to Chief Nursing Officer 3B Strengthens Its Commitment to the Nursing Market 60802 2Wolters Kluwer Health Appoints Anne Woods to Chief Nursing Officer 3B Strengthens Its Commitment to the Nursing Market 60802 3AVMA Updates H1N1 Flu Resources for Pet Owners Veterinarians 60797 1Helix BioPharma Corp Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha 2b in Patients With Ano Genital Warts 6036 1Helix BioPharma Corp Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha 2b in Patients With Ano Genital Warts 6036 2Helix BioPharma Corp Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha 2b in Patients With Ano Genital Warts 6036 3Helix BioPharma Corp Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha 2b in Patients With Ano Genital Warts 6036 4Helix BioPharma Corp Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha 2b in Patients With Ano Genital Warts 6036 5Helix BioPharma Corp Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha 2b in Patients With Ano Genital Warts 6036 6
(Date:11/27/2009)... Three new interactive anatomy education apps fr...expand health sciences learning opportunities for ...urham, NC (Vocus) November 27, 2009 -- Modality, ... a division of Wolters Kluwer Health, today announ...n apps on the App Store. Clemente’s Anatomy,...
(Date:11/26/2009)...ng drug tetrathiomolybdate (TM) has been shown in ... disease, a disease caused by an overload of coppe...own. Very little, however, is known about how the ... led by Northwestern University researchers now ha...al structure of TM bound to copper-loaded metalloc...
(Date:11/26/2009)... Dr. David Kim of the Live Life Again Center, a ... is one of a growing number of physicians who are ...es to connect with individuals who are interested ...obesity. Dr. Kim is utilizing Facebook to share be...actice with the community. , ...
(Date:11/25/2009)...., Nov. 25 When most pe...tist. But a chiropractor can also give patients t...dibular Joint, which is where your jaw (mandible) ... ,, The most common symptoms associated with T...popping of the jaw. But many other symptoms can b...
(Date:11/25/2009)...v. 25 /PRNewswire/ - Sentinelle Medical Inc., a le...d visualization software launches a suite of new l... medical imaging software platform at this year,s ...l meeting in Chicago, Nov. 30 - Dec. 5, 2009 (Boot...que high quality images generated by Sentinelle,s ...
Breaking Medicine News(10 mins):Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 4
Human Serum (All Male Donors) from Irvine Scientific
Human AB Serum from 3H Biomedical AB
Human HGF, Unconjugated from R&D Systems
Mouse MMP-9, Unconjugated from R&D Systems
Biology Products:
...f-the-art quality in an instrument of extremely lo...ty. Low profile cutting tips allow access to patho...re available in just about every cutting tip style...t arthroscopic procedures.,Arthrex offers a lifet...
...f-the-art quality in an instrument of extremely lo...ty. Low profile cutting tips allow access to patho...re available in just about every cutting tip style...t arthroscopic procedures.,Arthrex offers a lifet...
...f-the-art quality in an instrument of extremely lo...ty. Low profile cutting tips allow access to patho...re available in just about every cutting tip style...t arthroscopic procedures.,Arthrex offers a lifet...
...f-the-art quality in an instrument of extremely lo...ty. Low profile cutting tips allow access to patho...re available in just about every cutting tip style...t arthroscopic procedures.,Arthrex offers a lifet...
Medicine Products:
(Date:11/24/2009)...4 /PRNewswire-Asia/ -- NOD Pharmaceuticals Inc. an... has allowed the patent application for,its nano-p... NOD technology is a highly efficient approach to...e nano-particles to enable oral delivery of drugs,...gy is a platform technology,that can be applied to...
(Date:11/24/2009)...swire/ -- Blue Marble Energy Corp. announced today...t Authority (OPDA) were recently awarded $2 millio...ization Board (CERB) in a private/public partnersh...mical biorefinery in Lincoln County, WA. ,, "...opment of our biorefinery and bring over 70 green ...
(Date:11/24/2009)..., TORONTO, Nov. 24 /PRNewswire-FirstCall/ - Hamilt...tal Inc., a leading provider of advanced laser sys...d fertility clinic markets, today reported operati...nded September 30, 2009. , , Q3 2009 Highlight... $1.43 million in Q3 2008, - Gross profit mar...
(Date:11/24/2009)... Nov. 24 Genomic Health,...Scott, Genomic Health,s Executive Chairman, will p...e Conference in New York City on Tuesday, December...ve and subsequently archived webcast of the presen...nomic Health,s website at http://investor.genomic...
Breaking Biology Technology:Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Hamilton Thorne announces third quarter results 8Hamilton Thorne announces third quarter results 9Hamilton Thorne announces third quarter results 10Genomic Health to Present at Piper Jaffray Health Care Conference 2
(Date:11/25/2009)... The FDA granted traditional approv...-nucleoside reverse transcriptase inhibitor (NNRTI...ted for use in treatment-experienced adults who ar...s resistant to an NNRTI and other antiretroviral (... 48-week data from two Phase 3 studies known as DU...
(Date:11/25/2009)... 25 Regado Biosciences, a privatel...mbotic aptamers with active control agents, announ... be presenting at the Piper Jaffray 21st Annual He...in New York City. Dr. Mazzo,s presentation will b... will include an overview of the Company,s pipelin...
(Date:11/25/2009)... Abaxis, Inc. (Nasdaq: ...oint-of-care blood analysis systems, announced tod...ve officer, will present at the 21st Annual Piper ...ber 2, 2009 at 2:00 p.m. ET. The conference will b...ty. ,, About Abaxis ,, Abaxis develops, m...
Breaking Medicine Technology:U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 5Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2New synthetic molecules trigger immune response to HIV and prostate cancer 10644 1New synthetic molecules trigger immune response to HIV and prostate cancer 10644 2Cadence Pharmaceuticals Reports Third Quarter 2009 Financial Results 60787 1Cadence Pharmaceuticals Reports Third Quarter 2009 Financial Results 60787 2Cadence Pharmaceuticals Reports Third Quarter 2009 Financial Results 60787 3Cadence Pharmaceuticals Reports Third Quarter 2009 Financial Results 60787 4Cadence Pharmaceuticals Reports Third Quarter 2009 Financial Results 60787 5Cadence Pharmaceuticals Reports Third Quarter 2009 Financial Results 60787 6Cadence Pharmaceuticals Reports Third Quarter 2009 Financial Results 60787 7Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 14742 1Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 14742 2